Promising Respiratory Drug Focus of New Trial for Parkinson’s

Promising Respiratory Drug Focus of New Trial for Parkinson’s
The trial is the latest to be launched as part of the Linked Clinical Trials (LCT) initiative, a programme spearheaded by The Cure Parkinson’s Trust in collaboration with Van Andel Research Institute (VARI), Michigan, USA, with funding from VARI and the John Black Charitable Foundation. “With this trial, we’re moving beyond treating Parkinson’s symptoms. We want to actually slow or ... read more
Source: The Cure Parkinson’s TrustPublished on 2017-08-08